Plasmodium ovale

Plasmodium ovale

Languages: English


Brief Summary

Plasmodium ovale is one of the five described Plasmodium species that cause malaria in humans (with Plasmodium falciparum generally causing the most severe disease and most of the mortality from the disease).

Plasmodium ovale is generally thought of as having a relatively limited distribution, with endemic transmission traditionally described as being limited to areas of tropical Africa, New Guinea, the eastern parts of Indonesia, and the Philippines. However, P. ovale infections have also been reported from the Middle East, the Indian subcontinent, and parts of Southeast Asia. In West Africa (and to a lesser extent Central Africa), age specific prevalence (based on light microscopy, LM) of >10% has been observed. However, in most places where P. ovale is observed, it is relatively uncommon and its prevalence (as detected by LM) rarely exceeds 3–5%.  As is the case for P. malariae and P. falciparum, P. ovale infections in West African populations tend to be most common in children under ten years of age. Little is known about the potential for interaction between P. ovale and other malaria infections. However, the fact that P. ovale has been found to be most prevalent in areas of West Africa where P. vivax is nearly absent because of the virtual absence of the Duffy blood-group-antigen, which P. vivax requires to invade red blood cells, might indicate a negative interaction between these two species. (Mueller et al. 2007 and references therein)  Recent work indicates that there are likely two distinct Plasmodium species that have both been referred to as P. ovale (Sutherland et al. 2010; Oguike et al. 2011)

Like P. vivax, P. ovale has long been thought to have a dormant stage "hypnozoite" stage that can persist in the liver and cause relapses by invading the bloodstream weeks (or even years) later, but Richter et al. (2010) have questioned whether such a stage actually exists for P. ovale.

The human malaria parasite life cycle involves two hosts, a mosquito and a human. The life cycle is very complex, including both sexual and asexual phases (see life cycle diagram) and involves a stage in the liver as well as the blood stage, the latter being responsible for the clinical manifestations of the disease.  (Centers for Disease Control Parasites and Health website)

Author(s): Shapiro, Leo
Rights holder(s): Shapiro, Leo

Evolution and Systematics

Systematics and Taxonomy

There are more than 150 named species of Plasmodium that infect various species of vertebrates.  Four species are well known as true parasites of humans, utilizing humans almost exclusively as a natural intermediate host: P. falciparum, P. vivax, P. ovale  and P. malariae.  In recent years it has become apparent that the simian malaria parasite P. knowlesi also regularly infects humans, as well as its natural monkey intermediate hosts. (Centers for Disease Control Parasites and Health website)  Furthermore, it is now apparent that there are likely two distinct Plasmodium species that have both been referred to as P. ovale (Sutherland et al. 2010; Oguike et al. 2011).

Author(s): Shapiro, Leo
Rights holder(s): Shapiro, Leo


Mueller, I., Zimmerman P. A., & Reeder J. C. (2007).  Plasmodium malariae and Plasmodium ovale – the ‘bashful’ malaria parasites. Trends in Parasitology. 23(6), 278 - 283.
Oguike, M C., Betson M., Burke M., Nolder D., Stothard R. J., Kleinschmidt I., et al. (2011).  Plasmodium ovale curtisi and Plasmodium ovale wallikeri circulate simultaneously in African communities. International Journal for Parasitology. 41(6), 677 - 683.
Richter, J., Franken G., Mehlhorn H., Labisch A., & Häussinger D. (2010).  What is the evidence for the existence of Plasmodium ovale hypnozoites?. Parasitology Research. 107(6), 1285 - 1290.
Sutherland, C J.., Tanomsing N., Nolder D., Oguike M., Jennison C., Pukrittayakamee S., et al. (2010).  Two Nonrecombining Sympatric Forms of the Human Malaria Parasite Plasmodium ovale Occur Globally. The Journal of Infectious Diseases. 201(10), 1544 - 1550.